TerminatedNot Applicable

To Evaluate the Outcomes After Surgery for Necrotizing Soft Tissue Infections

Stopped: low accrual rate

United States13 participantsStarted 2019-07-01

Plain-language summary

There is significant mortality associated with necrotizing soft tissue infections, it is imperative to decrease mortality and complications associated with this disease is determined. To accomplish this goal, study team will create a prospectively maintained database of all NSTI patients admitted at department of surgery. Investigators will asses the predictors of poor outcome and follow these patients for 1 year in clinic and asses the functional quality of life by incorporating 36-Item Short Form Survey (SF-36) score.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: all patients ≥ 18 years presenting with necrotizing soft tissue infections admitted to Westchester Medical Center, who will undergo surgical management Exclusion Criteria: Age \< 18 years.

What they're measuring

30-day mortality. (Short term )

Timeframe: 30 days

Trial details

NCT IDNCT05032625

SponsorNew York Medical College

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-09-01

View on ClinicalTrials.gov More Necrotizing Soft Tissue Infection trials